Paper350387
A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetate.
Pannuti F and 4 others. Cancer Treat Rep, 1978. Cited by 101 papers, by iCite.
Cite this record
ConductScience Library. A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetate. Papers, record 350387. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/350387
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetate.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Medroxyprogesterone | Major topic |
| Adult | |
| Aged | |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Metastasis | |
| Time Factors |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 12172571 | The role of aromasin in the hormonal therapy of breast cancer. | Pathol Oncol Res | 2002 | https://conductscience.org/library/papers/12172571 | PubMed |
| 11091543 | Benefits of Medroxyprogesterone Acetate (MPA) in Advanced or Recurrent Breast Cancer with Higher Serum Concertration. | Breast Cancer | 1995 | https://conductscience.org/library/papers/11091543 | PubMed |
| 9443650 | Correlation of expression levels of P-glycoprotein with resistance to adriamycin in a renal adenocarcinoma cell line. | Urol Res | 1997 | https://conductscience.org/library/papers/9443650 | PubMed |
| 7438329 | Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routes. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/7438329 | PubMed |
| 6400037 | Chemotherapy of breast cancer. | Med Oncol Tumor Pharmacother | 1984 | https://conductscience.org/library/papers/6400037 | PubMed |
| 6225476 | Current status of high dose progestin treatment in advanced breast cancer. | Breast Cancer Res Treat | 1983 | https://conductscience.org/library/papers/6225476 | PubMed |
| 6224604 | Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administration in advanced cancer patients. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6224604 | PubMed |
| 6224603 | A phase II study of high-dose medroxyprogesterone acetate in advanced breast cancer. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6224603 | PubMed |
| 6216931 | Oral high-dose medroxyprogesterone acetate (MAP) in treatment of advanced breast cancer. A preliminary report of clinical and experimental studies. | Breast Cancer Res Treat | 1981 | https://conductscience.org/library/papers/6216931 | PubMed |
| 6213319 | Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6213319 | PubMed |
| 3427228 | Alternating tamoxifen and medroxyprogesterone acetate in postmenopausal advanced breast cancer patients--short and long term endocrine effects. | Breast Cancer Res Treat | 1987 | https://conductscience.org/library/papers/3427228 | PubMed |
| 3156002 | Lack of correlations between plasma concentration of medroxyprogesterone acetate, hypothalamic-pituitary function, and tumour response in patients with advanced breast cancer. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3156002 | PubMed |
| 2986666 | Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate. | Br J Cancer | 1985 | https://conductscience.org/library/papers/2986666 | PubMed |
| 2971386 | The pharmacokinetics of medroxyprogesterone acetate following two different loading dose schedules in advanced carcinoma of the breast. | Br J Cancer | 1988 | https://conductscience.org/library/papers/2971386 | PubMed |
| 2963170 | On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer. | Klin Wochenschr | 1987 | https://conductscience.org/library/papers/2963170 | PubMed |
| 2952154 | The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients. | Br J Cancer | 1987 | https://conductscience.org/library/papers/2952154 | PubMed |
| 2939693 | Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases. | Acta Neurochir (Wien) | 1986 | https://conductscience.org/library/papers/2939693 | PubMed |
| 2570093 | Endocrine therapy of metastatic breast cancer. | J Endocrinol Invest | 1989 | https://conductscience.org/library/papers/2570093 | PubMed |
| 2524303 | Clinical significance of differences in bioavailability of medroxyprogesterone acetate preparations. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2524303 | PubMed |
| 1828463 | Changes in hematologic parameters during treatment with medroxyprogesterone acetate for breast cancer. | Jpn J Cancer Res | 1991 | https://conductscience.org/library/papers/1828463 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/350387
GET https://conductscience.org/api/papers/v1/350387/cited_by?page=2